MILESTONE PHARMACEUTICALS INC.

Insiders Milestone Pharmaceuticals Inc.

Equities

MIST

CA59935V1076

Delayed Nasdaq Other stock markets 09:49:42 2024-05-14 am EDT			5-day change	1st Jan Change
1.75 ^USD	+2.94%		+0.57%	+4.79%

May. 13	Milestone Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Apr. 08	Milestone Pharmaceuticals Announces Etripamil Data Demonstrating Patients? Ability to Self-Manage Recurring PSVT, Presented at The American College of Cardiology Annual Meeting	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Milestone Pharmaceuticals Inc. Elects Seth H.Z. Fischer to the Board	23-03-27	CI
Milestone Pharmaceuticals Inc. Announces the Retirement of Francis Plat as Chief Scientific Officer, Effective December 31, 2022	22-12-06	CI
Milestone Pharmaceuticals Announces Management Changes	22-02-16	CI
Milestone Pharmaceuticals Inc. Announces Board Changes	20-11-13	CI
Milestone Pharmaceuticals Inc. Appoints Lisa Giles and Robert Wills to Board of Directors, Effective October 1, 2020	20-09-22	CI
Milestone Pharmaceuticals Inc Announces Promotion of Jeff Nelson to Chief Operating Officer	20-03-06	CI
Milestone Pharmaceuticals Inc. Announces Resignation of Marco Boorsma from its Board of Directors	19-12-03	CI
Milestone Pharmaceuticals Inc. Appoints Richard C. Pasternak to its Board of Directors and a Member of the Company's Compensation Committee	19-11-13	CI
Milestone Pharmaceuticals Inc. Announces Executive Changes	19-10-15	CI
Milestone Pharmaceuticals Inc. Announces Resignation of Nilesh Kumar from the Board of Directors	19-09-20	CI
Milestone Pharmaceuticals Announces Appointment of Amit Hasija as Chief Financial Officer and Executive Vice President of Corporate Development	19-09-10	CI
Milestone Pharmaceuticals Appoints Paul Edick as Chairman of Board of Directors	19-04-16	CI
Milestone Pharmaceuticals Inc. Appoints Michael Tomsicek to Board of Directors and Chairman of Audit Committee	19-04-04	CI
Milestone Pharmaceuticals USA Names Lorenz Muller as Chief Commercial Officer	17-10-26	CI
Milestone Pharmaceuticals Appoint Board of Directors	17-08-01	CI
Milestone Pharmaceuticals Inc. Announces United States Adopted Name Approval of Generic Name "Etripamil" for Phase 2 Clinical Development Product	16-01-25	CI
Milestone Pharmaceuticals Inc. Appoints Francis Plat as Chief Medical Officer	14-07-21	CI
Milestone Pharmaceuticals Inc. Announces Board Changes	12-03-05	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

SIGN UP NOW